Substantial progress has been made during the past 20 years in pregnancy management and outcomes in women with systemic lupus erythematosus (SLE), as Mehta and colleagues show in their current article in Annals (1). Thirty years ago, most women with SLE were advised to avoid pregnancy because of high risks for maternal and fetal morbidity and mortality. Now, this advice has shifted entirely, and most women with SLE, with careful management, can safely build a family thanks to several developments.
Many prospective cohorts of pregnant women with SLE have demonstrated that disease activity in the months before and during pregnancy ...
References
- 1.
Mehta B ,Luo Y ,Xu J ,et al . Trends in maternal and fetal outcomes among pregnant women with systemic lupus erythematosus in the United States. A cross-sectional analysis. Ann Intern Med. 2019;171:164-71. doi:10.7326/M19-0120 LinkGoogle Scholar - 2.
Fischer-Betz R ,Specker C . Pregnancy in systemic lupus erythematosus and antiphospholipid syndrome. Best Pract Res Clin Rheumatol. 2017;31:397-414. [PMID:29224680 ] doi:10.1016/j.berh.2017.09.011 CrossrefMedlineGoogle Scholar - 3.
Levy RA ,Vilela VS ,Cataldo MJ ,et al . Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus. 2001;10:401-4. [PMID:11434574 ] CrossrefMedlineGoogle Scholar - 4.
Eudy AM ,Siega-Riz AM ,Engel SM ,et al . Effect of pregnancy on disease flares in patients with systemic lupus erythematosus. Ann Rheum Dis. 2018;77:855-860. [PMID:29463519 ] doi:10.1136/annrheumdis-2017-212535 CrossrefMedlineGoogle Scholar - 5.
Bermas BL ,Kim SC ,Huybrechts K ,et al . Trends in use of hydroxychloroquine during pregnancy in systemic lupus erythematosus patients from 2001 to 2015. Lupus. 2018:961203317749046. [PMID:29301469 ] doi:10.1177/0961203317749046 CrossrefMedlineGoogle Scholar - 6. ACOG committee opinion no. 743: low-dose aspirin use during pregnancy. Obstet Gynecol. 2018;132:e44-e52. [PMID:
29939940 ] doi:10.1097/AOG.0000000000002708 CrossrefMedlineGoogle Scholar - 7.
LeFevre ML ;U.S. Preventive Services Task Force . Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;161:819-26. [PMID:25200125 ]. doi:10.7326/M14-1884 LinkGoogle Scholar - 8.
Mendel A ,Bernatsky SB ,Hanly JG ,et al . Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort. Ann Rheum Dis. 2018. [PMID:30573656 ] doi:10.1136/annrheumdis-2018-214434 CrossrefMedlineGoogle Scholar - 9.
Hughes GR . Hughes syndrome (the antiphospholipid syndrome): a disease of our time. Inflammopharmacology. 2011;19:69-73. [PMID:21132565 ] doi:10.1007/s10787-010-0071-3 CrossrefMedlineGoogle Scholar - 10. ACOG practice bulletin. Antepartum fetal surveillance. Number 9, October 1999 (replaces technical bulletin number 188, January 1994). Clinical management guidelines for obstetrician-gynecologists. Int J Gynaecol Obstet. 2000;68:175-85. [PMID:
10717828 ] CrossrefMedlineGoogle Scholar
Author, Article and Disclosure Information
Duke University Medical Center, Durham, North Carolina (M.E.C.)
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M19-1667.
Corresponding Author: Megan E.B. Clowse, MD, MPH, Duke University Medical Center, Box 3535, Trent Drive, Durham, NC 27710; e-mail, megan.
This article was published at Annals.org on 9 July 2019.
Submit a Comment
Contributors must reveal any conflict of interest. Comments are moderated. Please see our information for authorsregarding comments on an AIMCC publication.